Sign Up to like & get recommendations! 0
Published in 2018 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.27447
Abstract: Demonstrate proof‐of‐concept validation of a computed tomography (CT) computer‐aided design prediction modeling tool to identify patients at risk for left ventricular outflow tract (LVOT) obstruction in transcatheter mitral valve replacement (TMVR). read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29708
Abstract: Right ventricular outflow tract (RVOT) stenting improves systemic oxygenation and facilitates pulmonary arterial growth in symptomatic infants prior to repair of tetralogy of Fallot. The aim of this study was to evaluate the safety and… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30301
Abstract: Evaluate transcatheter heart valve (THV) geometry according to left ventricular outflow tract (LVOT) calcium degree and its impact on hemodynamics and outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) with a contemporary self‐expanding THV. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.1038
Abstract: Surgical intervention is used to treat dynamic left ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy. This study assesses the effect of different surgical strategies on long‐term mortality and morbidity. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.27307
Abstract: Myocardial strain for assessment of hypertrophic cardiomyopathy (HCM) is of importance and may play a role in identifying obstruction in HCM patients. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Prenatal Diagnosis"
DOI: 10.1002/pd.5378
Abstract: The pathophysiology of right ventricular outflow tract obstruction (RVOTO) in twin‐to‐twin transfusion syndrome (TTTS) recipients is incompletely understood. We aimed to investigate the development and spectrum of RVOTO in TTTS recipients. read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-020-06998-8
Abstract: Purpose Left ventricular outflow tract obstruction (LVOTO) is a relatively uncommon but severe condition that may lead to hemodynamic impairment. It can be elicited by morphological (left ventricular hypertrophy, sigmoid septum, prominent papillary muscle, prolonged… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-019-00612-0
Abstract: The aim of this study was to develop a new electrocardiographic criterion for differentiating the origin of outflow tract ventricular arrhythmias (OT-VAs) with precordial transition in lead V3. A total of 147 consecutive patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-021-00959-3
Abstract: To elucidate the electrophysiological predictors of the intramural origins of left ventricular outflow tract-ventricular tachyarrhythmias (LVOT-VAs), and to clarify the involvement of anatomical factors. Twenty-nine successfully ablated LVOT-VAs patients with origins in the aortomitral continuity… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Journal of Echocardiography"
DOI: 10.1007/s12574-017-0352-6
Abstract: BackgroundLeft ventricular outflow tract obstruction (LVOTO) occurs from not only obstructive hypertrophic cardiomyopathy but also other conditions such as sigmoid septum or post mitral valve repair. However, the changes of the LVOT pressure gradient (LVOT… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Acta biomaterialia"
DOI: 10.1016/j.actbio.2021.01.022
Abstract: For decades, researchers have investigated the ideal material for clinical use in the cardiovascular field. Several substitute materials are used clinically, but each has drawbacks. Recently we developed biodegradable and elastic poly(ε-caprolactone-co-D,L-lactide) (P(CL-DLLA)) copolymers by… read more here.